YENOM NOTICIAS
Noticias financieras organizadas para conectar titulares, símbolos, fuente, fecha y sentimiento con tu análisis y operativa.
Si escribes ticker, YENOM prioriza ese instrumento. Si lo dejas vacío puedes explorar el feed general o por tema.
* Valneva press release [https://seekingalpha.com/pr/20617691-valneva-reports-half-year-2026-financial-results-and-provides-corporate-updates] (VALN [https://seekingalpha.com/symbol/VALN]): 1H GAAP EPS of -€0.35. * Revenue of €65.84M (-32.…
This article first appeared on GuruFocus. Release Date: March 18, 2026 For the complete transcript of the earnings call, please refer to the full earnings call transcript. Positive Points Valneva SE (INRLF) reported total revenues exceedin…
* Valneva press release [https://seekingalpha.com/pr/20441902-valneva-reports-full-year-2025-audited-consolidated-financial-results] (VALN [https://seekingalpha.com/symbol/VALN]): FY Revenue of €174.7M (+3.0% Y/Y), including €157.9 million…
VALNEVA Total Revenues of €174.7 million in line with guidance, including €157.9 million in product sales Strong year-end cash position of €109.7 million, with enhanced financial flexibility following successful debt refinancing 2026 to be…
Valneva said that antibody levels remained well above baseline across all six Lyme disease serotypes and all age groups in the trial. Continue Reading View Comments
VALNEVA Antibody levels remained well above baseline across all six serotypes and age groups sixth month after third yearly booster dose No safety concerns observed in any age group by an independent Data Monitoring Committee (DMC) Results…
VALNEVA VALNEVA Declaration of shares and voting rights October 31, 2025 __________________________________________________________________________________________ Company name: VALNEVA Registered office: 6 rue Alain Bombard, 44800 Saint-H…
VALNEVA Immune response successfully improved with second generation vaccine candidate Saint-Herblain (France), November 4, 2025 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced positive result…
In recent weeks, European markets have experienced mixed performance, with the pan-European STOXX Europe 600 Index declining slightly and major indices showing varied results amid shifting expectations for interest rate cuts from the Europ…
VALNEVA Saint-Herblain (France), October 27, 2025 –Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced that its senior management will present and participate in 1-on-1 meetings with institutional i…
VALNEVA New debt facility extends repayment from Q1 2026 to Q4 2030, lowers interest rate and provides access to additional capital for future business development Company adjusts 2025 financial guidance and provides key business updates S…
VALNEVA VALNEVA Declaration of shares and voting rights September 30, 2025 __________________________________________________________________________________________ Company name: VALNEVA Registered office: 6 rue Alain Bombard, 44800 Saint…
VALNEVA Long-lasting antibody persistence was comparable in older (65+) and younger adults Long-term antibody persistence is a key competitive advantage for a vaccine targeting unpredictable outbreak diseases like chikungunya Saint-Herblai…
Some half a million cases of Lyme disease occur each year in the U.S., plus another 130,000 in Europe. Continue Reading View Comments
VALNEVA VALNEVA Declaration of shares and voting rights August 31, 2025 __________________________________________________________________________________________ Company name: VALNEVA Registered office: 6 rue Alain Bombard, 44800 Saint-He…
VALNEVA Strong immune response after third yearly booster dose in children and adults Significant anamnestic antibody response across all six serotypes No safety concerns observed in any age group by independent Data Monitoring Committee (…
VALNEVA Saint Herblain (France), August 25, 2025 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced that the United States Food and Drug Administration (FDA) has suspended the license for IXCHIQ®…
VALNEVA Saint Herblain (France), August 18, 2025 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced that Health Canada has granted marketing authorization for its single-dose vaccine, IXCHIQ®, fo…
* Valneva press release [https://seekingalpha.com/pr/20196941-valneva-reports-half-year-2025-financial-results-and-provides-corporate-updates] (NASDAQ:VALN [https://seekingalpha.com/symbol/VALN]): 1H net loss of €20.8 million compared to a…
VALNEVA Total revenues of €97.6 million compared to €70.8 million in the first half of 2024 Cash and cash equivalents of €161.3 million at end of June 2025 Further clinical and regulatory progress 2025 financial outlook confirmed Saint-Her…
[Medical form with diagnosis Chikungunya in a hospital.] designer491/iStock via Getty Images Valneva SE (NASDAQ:VALN [https://seekingalpha.com/symbol/VALN]) said on Thursday that the FDA has lifted its pause on the use of its chikungunya v…
VALNEVA Saint Herblain (France), August 7, 2025 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced that the FDA has removed its recommended pause in the use of IXCHIQ® in individuals 60 years of…
VALNEVA VALNEVA Declaration of shares and voting rights July 31, 2025 __________________________________________________________________________________________ Company name: VALNEVA Registered office: 6 rue Alain Bombard, 44800 Saint-Herb…
As the pan-European STOXX Europe 600 Index remains relatively flat amid ongoing U.S. and European trade talks, major stock indexes in Europe show mixed results with Italy’s FTSE MIB gaining slightly and Germany's DAX and France's CAC 40 In…
VALNEVA Saint Herblain (France), July, 11 2025 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced that the European Medicines Agency (EMA) will lift the temporary restriction on vaccinating peopl…
VALNEVA VALNEVA Declaration of shares and voting rights June 30, 2025 __________________________________________________________________________________________ Company name: VALNEVA Registered office: 6 rue Alain Bombard, 44800 Saint-Herb…
VALNEVA Saint-Herblain, France, June 26, 2025 – Valneva SE, (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced an exclusive agreement with CSL Seqirus, one of the world’s largest influenza vaccine companies,…
VALNEVA Saint-Herblain (France), June 25, 2025 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced that all the resolutions recommended by the Board of Directors were approved by the shareholders…
VALNEVA IXCHIQ®was well tolerated by children aged one to eleven years regardless of the dose or previous chikungunya infection (CHIKV) Antibody levels remained high after six months in both dose groups, although more robust with the full…
VALNEVA VALNEVA Declaration of shares and voting rights May 31, 2025 __________________________________________________________________________________________ Company name: VALNEVA Registered office: 6 rue Alain Bombard, 44800 Saint-Herbl…
VALNEVA Saint-Herblain (France), June 4, 2025 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company (“the Company”), today announced the availability of documentation for its Combined General Meeting (“the Meeting”)…
VALNEVA Saint-Herblain (France), May 26, 2025 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced that its senior management will present and hold investor meetings at several upcoming investor co…
The European market has shown resilience, with the pan-European STOXX Europe 600 Index rising for a fourth consecutive week amid optimism over easing trade tensions between China and the U.S., while Germany's DAX and Italy's FTSE MIB poste…
VALNEVA Saint Herblain (France), May, 12 2025 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced that the U.S. Food and Drug Association (FDA) and the U.S. Centers for Disease Control and Prevent…
VALNEVA VALNEVA Declaration of shares and voting rights April 30, 2025 __________________________________________________________________________________________ Company name: VALNEVA Registered office: 6 rue Alain Bombard, 44800 Saint-Her…
VALNEVA Saint Herblain (France), May, 07 2025 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced that the European Medicines Agency (EMA) has started a review of Valneva’s single-dose live attenu…